DMG MORI (GIL) Q3 2025 earnings summary

Executive summary

• Q3 2025 order intake reached €590.0 million, up 17% year-over-year, with nine-month order intake stable at €1,731.7 million.

• Sales revenues declined 12% year-over-year to €1,409.2 million for the first nine months, with Q3 sales down 9% to €456.7 million.

• EBIT for the nine-month period dropped 59% to €61.2 million, with a margin of 4.3% versus 9.3% last year.

• Free cash flow was negative at €-12.2 million, slightly lower than the previous year's €-10.6 million.

• EMO Hannover 2025 showcased 29 innovations, including 18 world premieres and new automation solutions.

Financial highlights

• Q3 2025 order intake: €590.0 million (+17% year-over-year); nine-month order intake: €1,731.7 million (flat year-over-year).

• Q3 2025 sales revenues: €456.7 million (-9% year-over-year); nine-month sales: €1,409.2 million (-12% year-over-year).

• Q3 2025 EBITDA: €35.5 million (-43% year-over-year); nine-month EBITDA: €117.8 million (-42% year-over-year).

• Q3 2025 EBIT: €16.3 million (-62% year-over-year); nine-month EBIT: €61.2 million (-59% year-over-year).

• EAT for nine months rose to €148.3 million, driven by €101.9 million from discontinued operations, including a compensation payment for the Ulyanovsk plant.

Outlook and guidance

• Full-year 2025 order intake forecast revised to €2.2–2.3 billion (previously €2.4–2.5 billion).

• Sales revenues expected at €2.0–2.1 billion (previously €2.2–2.3 billion).

• EBIT guidance lowered to €100–120 million (previously €150–160 million).

• Free cash flow forecast at €60–90 million (previously €110–130 million).

• Company remains well positioned for 2026 with a strong order backlog and ongoing investments.